Imbio PHA (4.0.0) vs TeraRecon Cardiac.Chambers.MR
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Imbio PHA specializes in analyzing CT pulmonary angiogram scans to assess right ventricular dilation and aid in the diagnosis of pulmonary embolism and hypertension. In contrast, TeraRecon Cardiac.Chambers.MR processes MR images for automatic cardiac chamber segmentation, volumetric analysis, and ejection fraction calculations. While both are FDA-cleared AI tools for cardiac imaging, their distinct input modalities and specific diagnostic applications make them suitable for different clinical workflows.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Imbio PHA (4.0.0) is designed to process CT pulmonary angiogram (CTPA) scans. TeraRecon Cardiac.Chambers.MR, in contrast, analyzes DICOM-compliant contrast or non-contrast MR images.
Imbio PHA (4.0.0) automatically measures right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios. TeraRecon Cardiac.Chambers.MR provides automatic segmentation of cardiac chambers (LV, RV), volumetric analysis of ejection fraction, LV/RV inner and outer contour detection, and MR flow analysis capabilities, supporting the AHA 17 segmentation model.
Imbio PHA (4.0.0) assesses potential right ventricular dilation and aids in the diagnosis and risk stratification of pulmonary embolism and hypertension. TeraRecon Cardiac.Chambers.MR assists physicians in diagnosis and treatment planning through automatic segmentation of cardiac chambers from MR images.
Imbio PHA (4.0.0) generates annotated DICOM images and provides summary reports in PDF format, integrating with native DICOM tools and workflows. TeraRecon Cardiac.Chambers.MR outputs DICOM files for interoperability with PACS and other systems.